BIOMAT Database Logo BIOMAT Database Logo

[Humoral and cellular immunologic phenomena in patients with ankylosing spondylitis]. 1982

D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D011414 Properdin A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections. Complement Factor P,Factor P, Complement
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005260 Female Females

Related Publications

D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
[Humoral immunological phenomena in ankylosing spondylitis patients].
January 1980, Reumatologia,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
[Immunologic disorders in ankylosing spondylitis].
January 1981, Terapevticheskii arkhiv,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
[Immunologic thrombocytopenic purpura in ankylosing spondylitis].
March 1990, Presse medicale (Paris, France : 1983),
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
Immunologic phenomena in experimental rodentiosis. II. Cellular and humoral factors in immunity to infection with Yersinia pseudotuberculosis.
January 1976, Archivum immunologiae et therapiae experimentalis,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
Thymic humoral factor effect on intracellular lymphocyte cAMP in patients with ankylosing spondylitis.
January 1982, The Journal of rheumatology,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
[Cellular immunity during ankylosing spondylitis].
June 1980, Revue du rhumatisme et des maladies osteo-articulaires,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
[Humoral and cellular immunologic deficiency in lymphogranulomatosis].
November 1972, Orvosi hetilap,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
[Cellular and humoral immunologic response in pregnancy].
January 1976, Folia medica Cracoviensia,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
Postsalmonella reactive phenomena in 2 patients with ankylosing spondylitis: no modification of the underlying disease.
February 1990, The Journal of rheumatology,
D Dukalska, and D Friedek, and S Scheller, and M Kozioł, and T Kozak, and G Gazda
Uveitis in Patients with Ankylosing Spondylitis.
April 2021, Journal of Nepal Health Research Council,
Copied contents to your clipboard!